Our study indicated that upon anaphylaxis, vaccinated mice had higher levels of serum IFN-γ than unvaccinated mice, which suggested that pre-treatment with mRNA vaccines could partially shift allergen-specific Th2 T-cell response to the Th1 phenotype. This evidence concerns the gene IFNG and anaphylaxis.